| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Astrana Health (NASDAQ:ASTH) affirms FY2025 sales outlook from $3.100 billion-$3.300 billion to $3.100 billion-$3.300 billion v...
Astrana Health (NASDAQ:ASTH) sees Q3 sales of $925.000 million-$965.000 million vs $761.093 million analyst estimate.
Astrana Health (NASDAQ:ASTH) reported quarterly earnings of $0.19 per share which missed the analyst consensus estimate of $0.3...
Astrana Health (NASDAQ:ASTH) sees Q2 sales of $615.000 million-$655.000 million vs $660.68 million analyst estimate.